ASO Visual Abstract: Risk of Surgical Overtreatment in cN1 Breast Cancer Patients Who Become ypN0 After Neoadjuvant Chemotherapy: SLNB Versus TAD.

MLA

Laws, Alison, et al. “ASO Visual Abstract: Risk of Surgical Overtreatment in CN1 Breast Cancer Patients Who Become YpN0 After Neoadjuvant Chemotherapy: SLNB Versus TAD.” Annals of Surgical Oncology, Feb. 2025. EBSCOhost, https://doi.org/10.1245/s10434-025-16952-3.

APA

Laws, A., Leonard, S., Vincuilla, J., Parker, T., Kantor, O., Mittendorf, E. A., Weiss, A., & King, T. A. (2025). ASO Visual Abstract: Risk of Surgical Overtreatment in cN1 Breast Cancer Patients Who Become ypN0 After Neoadjuvant Chemotherapy: SLNB Versus TAD. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-025-16952-3

Chicago

Laws, Alison, Saskia Leonard, Julie Vincuilla, Tonia Parker, Olga Kantor, Elizabeth A Mittendorf, Anna Weiss, and Tari A King. 2025. “ASO Visual Abstract: Risk of Surgical Overtreatment in CN1 Breast Cancer Patients Who Become YpN0 After Neoadjuvant Chemotherapy: SLNB Versus TAD.” Annals of Surgical Oncology, February. doi:10.1245/s10434-025-16952-3.